Back to results

CompletedPhase 2

Nilotinib in Parkinson's Disease

NCT03205488

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama at Birmingham

Birmingham, Alabama, United States

+23 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2017-10-16
Enrollment: 76 participants
Sponsor: Northwestern University
Purpose: treatment

Locations (24)

University of Alabama at BirminghamBirmingham, Alabama, United States
Barrow Neurological InstituteSun City, Arizona, United States
University of California DavisSacramento, California, United States
University of Colorado at DenverAurora, Colorado, United States
University of FloridaGainesville, Florida, United States
University of South FloridaTampa, Florida, United States
Rush University Medical CenterChicago, Illinois, United States
John Hopkins UniversityBaltimore, Maryland, United States
Massachusetts General HospitalBoston, Massachusetts, United States
University of MichiganAnn Arbor, Michigan, United States
Michigan State UniversityEast Lansing, Michigan, United States
Cleveland Clinic - Las VegasLas Vegas, Nevada, United States
Albany Medical CollegeAlbany, New York, United States
Beth Israel Medical CenterNew York, New York, United States
Duke University Medical CenterDurham, North Carolina, United States
University of CincinnatiCincinnati, Ohio, United States
Cleveland ClinicCleveland, Ohio, United States
Oregon Health and Science UniversityPortland, Oregon, United States
University of PennsylvaniaPhiladelphia, Pennsylvania, United States
Medical University of South CarolinaCharleston, South Carolina, United States
Baylor College of MedicineHouston, Texas, United States
University of VirginiaCharlottesville, Virginia, United States
Inland Northwest ResearchSpokane, Washington, United States
Medical College of WisconsinMilwaukee, Wisconsin, United States

Nilotinib in Parkinson's Disease — TrialFind